-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that biotech company Lycia Therapeutics announced initial public offering (IPO) terms on Tuesday. The South San Francisco, California-based company plans to raise $250 million by issuing 14.7 million shares, with an issue price range of $16 to $18 per share. Based on the midpoint of the proposed offering price range, the fully diluted market value of Lycia Therapeutics will reach approximately US$950 million.

Zhitongcaijing·10/21/2026 07:01:18
Listen to the news
The Zhitong Finance App learned that biotech company Lycia Therapeutics announced initial public offering (IPO) terms on Tuesday. The South San Francisco, California-based company plans to raise $250 million by issuing 14.7 million shares, with an issue price range of $16 to $18 per share. Based on the midpoint of the proposed offering price range, the fully diluted market value of Lycia Therapeutics will reach approximately US$950 million.